Business NewsPR NewsWire • ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

NEW YORK, Sept. 19, 2021 /PRNewswire/ -- WHY: New York, N.Y., September 19, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between December 27, 2018 and August 5, 2021, inclusive (the "Class...

View More : https://www.prnewswire.com:443/news-releases/rosen-leading-and-longstanding-investor-counsel-encourages-spectrum-pharmac...
Releted News by prnewswire
Automotive Lighting Market | Increasing Demand For Effective Interior Lighting to Boost Growth |17000 + Technavio
CGTN:24 hopefuls in CGTN Media Challengers campaign face final competition
USD 39.76 Billion Growth expected in "Display Market" by 2025 | Sourcing and Procurement Report | SpendEdge
ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
IDEA Pharma et Protodigm agrandissent et renforcent leur équipe avec des experts chevronnés du secteur
IDEA Pharma und Protodigm erweitern und verstärken ihr Team mit ausgewiesenen Branchenexperten
IDEA Pharma y Protodigm amplían y refuerzan el equipo con expertos de la industria